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DELIVERABLES year 2, DIVA diagnostics
A validation plan for DIVA vaccines for CSFV. 
DIVA vaccines and diagnostic for CSFV 
have been used for more than 10 years. 
Practical use and lessons learned
First data on validation of DIVA tests for AI 
and BT. Considering DIVA diagnostics in 
vaccine policies for emerging diseases is 
important
3 WORKSHOPS ON FMD-NSP FOR 
AUTHORITIES AND STAKEHOLDERS 
Part I for Central Europe (Jan 2007)
Part II for South East Europe (June 2007)
Part III for Central Europe, Baltic and Nordic 
countries (Oct 2007) 
The workshops were Co-sponsored by EPIZONE, TAIEX, FAO-
EUFMD, EU CA-FMD-CSF and took place in Belgium.
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 P1, CIDC, NL; Willie Loeffen
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 P4, IAH, UK; Satya Parida
 P5, VLA, UK; Helen Everet
 P6, AFSSA, SE; Stephan Zientara
 P7, Vet-DTU, DK; Åse Uttenthal
 P8, SVA, SE; Frederik Widén
 P9, CIRAD, FR; Emmanuel Albina
 P10, CISA-INIA, ES; Alejandro Brun
 P11, ISZ-Vem, IT; William Dundon
 P12, LVRI, CH; Hong Yin
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 P14, SAP, TR; Naci Bulut
 P15, VAR, BE; Kris de Clercq
 P16, HVS, DE; Sabine Kühne
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PLANS for year 3, DIVA diagnostics
D. 4.3.10. Validation of commercial DIVA kits in pigs 
vaccinated by CSFV chimeric vaccine P7, P3
D. 4.3.11: Report on AIV ringtrial P11, P1, P3, P5, 
P6, P7, P15 
D. 4.3.13 Ringtrial on commercial CSFV-DIVA kits 
P16, P7, P3, P1, P15
D. 4.3.14 Confirmatory DIVA diagnostics on FMDV 
P4, P3
D. 4.3.15 Genetic CSFV DIVA diagnostics P8, P5, P3
D. 4.3.16 Feasibility study of BT DIVA on NSP 
proteins P6, P9
TASKS OF WP 4.3, DIVA diagnostics
1. Establishment of a DIVA network
2. Repositories of knowledge and reference 
materials
3. Validation of new DIVA diagnostic systems
4. Development of confirmatory tests
5. Standardization of DIVA diagnostics
o DIVA vaccines and diagnostics
will improve the vaccinate-to-
live strategy for domestic pig, 
back yard pig and wild boar
